The latest news and information about what's going on with SCI science and research.
A research project about an extremely complex process of interrupting nerve cell suicide generated some nice press in the past couple of days. This coverage, which offers a sort of high-altitude view of the work, was generated by a well-rendered media release from the Salk Institute: “Salk Scientist Discovers Novel Mechanism in Spinal Cord Injury
.” You know your press release was a good one when news outlets reprint it verbatim, and that’s what I’ve seen in this case. Read More
Riluzole, a drug approved already for treating ALS, has been shown in a Phase I safety trial, yes, to be safe. These results, published last week in the Journal of Neurotrauma
, also showed the drug may help patients regain some motor function if they get it within 12 hours of injury. Read More
You have heard this before: Animal research that seemed so promising in animal therapies flopped when tried in humans. Sure, animal models are limited, and there are very distinct biological differences between species. But that‘s not the whole story. Flawed trial design and investigator bias are part of the problem too.
That’s the conclusion of a paper from a team from Stanford, led by John P. A. Ioannidis. They looked specifically at research in neurological disorders, including Parkinson’s disease, stroke, MS and spinal cord injury. Read More
This is a cool science story from Japan this week, reported in one of the top journals, Nature. Human stem cells formed little “liver buds” and when transplanted into lab animals, developed blood vessels and became functional. Read More